Geode Capital Management’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-892,301
Closed -$5.06M 4547
2025
Q3
$5.06M Buy
892,301
+142,817
+19% +$731K ﹤0.01% 2771
2025
Q2
$2.86M Sell
749,484
-57,996
-7% -$180K ﹤0.01% 3012
2025
Q1
$2.12M Buy
807,480
+56,987
+8% +$186K ﹤0.01% 3011
2024
Q4
$2.66M Buy
750,493
+107,151
+17% +$410K ﹤0.01% 3032
2024
Q3
$2.93M Buy
643,342
+61,582
+11% +$298K ﹤0.01% 3006
2024
Q2
$2.53M Buy
581,760
+39,917
+7% +$175K ﹤0.01% 3054
2024
Q1
$2.72M Buy
541,843
+4,095
+0.8% +$22.9K ﹤0.01% 2993
2023
Q4
$3.37M Buy
537,748
+25,927
+5% +$148K ﹤0.01% 2892
2023
Q3
$3.64M Buy
511,821
+66,107
+15% +$521K ﹤0.01% 2796
2023
Q2
$4.54M Buy
445,714
+274,270
+160% +$2.86M ﹤0.01% 2732
2023
Q1
$1.55M Buy
171,444
+74,523
+77% +$546K ﹤0.01% 3140
2022
Q4
$694K Buy
96,921
+11,736
+14% +$71.7K ﹤0.01% 3528
2022
Q3
$555K Buy
85,185
+6,611
+8% +$35.3K ﹤0.01% 3667
2022
Q2
$378K Buy
78,574
+9,322
+13% +$46.1K ﹤0.01% 3908
2022
Q1
$393K Sell
69,252
-1,957
-3% -$9.61K ﹤0.01% 4065
2021
Q4
$357K Sell
71,209
-14
-0% -$77 ﹤0.01% 4214
2021
Q3
$473K Buy
71,223
+4,748
+7% +$28.4K ﹤0.01% 4054
2021
Q2
$406K Sell
66,475
-31,605
-32% -$191K ﹤0.01% 4035
2021
Q1
$652K Buy
98,080
+6,560
+7% +$45K ﹤0.01% 3717
2020
Q4
$484K Buy
91,520
+6,273
+7% +$49.1K ﹤0.01% 3600
2020
Q3
$635K Buy
85,247
+9,995
+13% +$78.1K ﹤0.01% 3360
2020
Q2
$553K Buy
75,252
+44,224
+143% +$388K ﹤0.01% 3334
2020
Q1
$229K Hold
31,028
﹤0.01% 3507
2019
Q4
$175K Sell
31,028
-1,655
-5% -$8.47K ﹤0.01% 3842
2019
Q3
$193K Hold
32,683
﹤0.01% 3780
2019
Q2
$104K Sell
32,683
-22,360
-41% -$73.1K ﹤0.01% 3951
2019
Q1
$165K Buy
55,043
+3,123
+6% +$10.7K ﹤0.01% 3783
2018
Q4
$195K Buy
51,920
+1,635
+3% +$7.68K ﹤0.01% 3688
2018
Q3
$295K Buy
50,285
+3,484
+7% +$17.7K ﹤0.01% 3631
2018
Q2
$264K Buy
46,801
+6,353
+16% +$65.3K ﹤0.01% 3646
2018
Q1
$501K Buy
+40,448
New +$544K ﹤0.01% 3391